Clinical Trial Update: OPTImal Management of Antithrombotic Agents: OPTIMA-5 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for OPTIMA-5 on managing antithrombotic agents in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Acute Coronary Syndrome (ACS) | Phase 4 | Status: UNKNOWN